X.-H. Shu et al. / Biochemical Pharmacology 79 (2010) 1516–1525
1525
[21] Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, et al.
Beta-catenin status predicts a favorable outcome in childhood medulloblas-
toma: the United Kingdom Children’s Cancer Study Group Brain Tumour
Committee. J Clin Oncol 2005;23:7951–7.
[22] Marino S. Medulloblastoma: developmental mechanisms out of control.
Trends Mol Med 2005;11:17–22.
[23] Liu J, Guo L, Luo Y, Li JW, Li H. All trans-retinoic acid suppresses in vitro growth
and down-regulates LIF gene expression as well as telomerase activity of
human medulloblastoma cells. Anticancer Res 2000;20:2659–64.
[24] Wang Q, Li H, Wang XW, Wu DC, Chen XY, Liu J. Resveratrol promotes
differentiation and induces Fas-independent apoptosis of human medullo-
blastoma cells. Neurosci Lett 2003;351:83–6.
[25] Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, Silber JR. Establish-
ment and characterization of four human medulloblastoma-derived cell lines.
Oncol Res 1995;7:493–503.
[26] Chen X, He H, Wang G, Yang B, Ren W, Ma L, et al. Stereospecific determination
of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmaco-
kinetic studies. Biomed Chromatogr 2007;21:257–65.
[27] Mercolini L, Addolorata Saracino M, Bugamelli F, Ferranti A, Malaguti M, Hrelia
S, et al. HPLC-F analysis of melatonin and resveratrol isomers in wine using an
SPE procedure. J Sep Sci 2008;31:1007–14.
[28] Qian G, Leung SY, Lu G, Leung KS. Optimization and validation of a chro-
matographic method for the simultaneous quantification of six bioactive
compounds in Rhizoma et Radix Polygoni Cuspidati. J Pharm Pharmacol
2008;60:107–13.
[29] Boocock DJ, Patel KR, Faust GE, Normolle DP, Marczylo TH, Crowell JA, et al.
Quantitation of trans-resveratrol and detection of its metabolites in human
plasma and urine by high performance liquid chromatography. J Chromatogr B
2007;848:182–7.
Acknowledgments
We gratefully acknowledge Hui Wang, Jing-Ping Cao and
Ying Gao for their assistance with the HPLC and LC/MS
detection. We thank Drs. Xin-Feng Zhao and Peng Gao for their
assistance with the HRMS analysis and Professor Xiang-Hong
Yang for providing human medulloblastoma specimens. This
work is supported by the grants from National Natural Science
Foundation of China (Nos. 30527002, 30670946 and 30971038)
and by the special grants of Liaoning Department of Education
for the key laboratory (20060193) and for the creative research
team (2007-7-26 and 2008T028).
References
[1] Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer
chemopreventive activity of resveratrol,
grapes. Science 1997;275:218–20.
[2] Dixon RA. Natural products and plant disease resistance. Nature 2001;411:
843–7.
[3] Rivera L, Moro´n R, Zarzuelo A, Galisteo M. Long-term resveratrol administra-
tion reduces metabolic disturbances and lowers blood pressure in obese
Zucker rats. Biochem Pharmacol 2009;77:1053–63.
[4] Burstein B, Maguy A, Cle´ment R, Gosselin H, Poulin F, Ethier N, et al. Effects of
resveratrol (trans-3,5,40-trihydroxystilbene) treatment on cardiac remodeling
following myocardial infarction. J Pharmacol Exp Ther 2007;323:916–23.
[5] Olas B, Wachowicz B. Resveratrol and vitamin C as antioxidants in blood
platelets. Thromb Res 2002;106:143–8.
a natural product derived from
[30] Urpi-Sarda M, Zamora-Ros R, Lamuela-Raventos R, Cherubini A, Jauregui O, de
la Torre R, et al. HPLC-tandem mass spectrometric method to characterize
resveratrol metabolism in humans. Clin Chem 2007;53:292–9.
[31] Salman ED, Kadlubar SA, Falany CN. Expression and localization of cytosolic
sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain. Drug Metab
Dispos 2009;37:706–9.
[6] Zhu J, Yong W, Wu X, Yu Y, Lv J, Liu C, et al. Anti-inflammatory effect of
resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem
Biophys Res Commun 2008;369:471–7.
[32] Liyou NE, Buller KM, Tresillian MJ, Elvin CM, Scott HL, Dodd PR, et al. Locali-
zation of a brain sulfotransferase, SULT4A1, in the human and rat brain: an
immunohistochemical study. J Histochem Cytochem 2003;51:1655–64.
[33] Allali-Hassani A, Pan PW, Dombrovski L, Najmanovich R, Tempel W, Dong A,
et al. Structural and chemical profiling of the human cytosolic sulfotrans-
ferases. PLoS Biol 2007;5:1063–78.
[34] Hui Y, Yasuda S, Liu MY, Wu YY, Liu MC. On the sulfation and methylation of
catecholestrogens in human mammary epithelial cells and breast cancer cells.
Biol Pharm Bull 2008;31:769–73.
[35] Wang DG, Hang TJ, Wu CY, Liu WY. Identification of the major metabolites of
resveratrol in rat urine by HPLC-MS/MS. J Chromatogr B 2005;829:97–106.
[36] Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, et al.
Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransfer-
ase 1A1 expression on cell growth inhibition. Cancer Lett 2008;261:172–81.
[37] Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low
bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004;32:
1377–82.
[38] Alnouti Y, Klaassen CD. Tissue distribution and ontogeny of sulfotransferase
enzymes in mice. Toxicol Sci 2006;93:242–55.
[39] Lindsay J, Wang LL, Li Y, Zhou SF. Structure, function and polymorphism of
human cytosolic sulfotransferases. Curr Drug Metab 2008;39:99–105.
[40] Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence.
Nat Rev Drug Discov 2006;5:493–506.
[41] Lanc¸on A, Hanet N, Jannin B, Delmas D, Heydel JM, Lizard G, et al. Resveratrol in
human hepatoma HepG2 cells: metabolism and inducibility of detoxifying
enzymes. Drug Metab Dispos 2007;35:699–703.
[42] Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small
molecule activators of sirtuins extend Saccharomyces cerevisiae life span.
Nature 2003;425:191–6.
[7] Shakibaei M, Csaki C, Nebrich S, Mobasheri A. Resveratrol suppresses inter-
leukin-1beta-induced inflammatory signaling and apoptosis in human articu-
lar chondrocytes: potential for use as a novel nutraceutical for the treatment of
osteoarthritis. Biochem Pharmacol 2008;76:1426–39.
[8] Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, Young HA, et al.
Inhibition of prostate cancer growth by muscadine grape skin extract and
resveratrol through distinct mechanisms. Cancer Res 2007;67:8396–405.
[9] Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N. Chemoprevention of skin
cancer by grape constituent resveratrol: relevance to human disease? FASEB J
2005;19:1193–5.
´
[10] Boissy P, Andersen TL, Abdallah BM, Kassem M, Plesner T, Delaisse JM.
Resveratrol inhibits myeloma cell growth, prevents osteoclast formation,
and promotes osteoblast differentiation. Cancer Res 2005;65:9943–52.
[11] Zhang P, Li H, Wu ML, Chen XY, Kong QY, Wang XW, et al. c-Myc down-
regulation: a critical molecular event in resveratrol-induced cell cycle
arrest and apoptosis of human medulloblastoma cells.
2006;80:123–31.
J Neurooncol
[12] Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS. Resveratrol prevents
doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1
pathway. Free Radic Biol Med 2009;46:1589–97.
[13] Venkatesan B, Ghosh-Choudhury N, Das F, Mahimainathan L, Kamat A, Kasi-
nath BS, et al. Resveratrol inhibits PDGF receptor mitogenic signaling in
mesangial cells: role of PTP1B. FASEB J 2008;22:3469–82.
[14] Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, et al. Resveratrol
protects against global cerebral ischemic injury in gerbils. Brain Res 2002;958:
439–47.
[15] Wang Q, Li H, Liu N, Chen XY, Wu ML, Zhang KL, et al. Correlative analyses of
notch signaling with resveratrol-induced differentiation and apoptosis of
human medulloblastoma cells. Neurosci Lett 2008;438:168–73.
[16] Yu LJ, Wu ML, Li H, Chen XY, Wang Q, Sun Y, et al. Inhibition of STAT3
expression and signaling in resveratrol-differentiated medulloblastoma cells.
Neoplasia 2008;10:736–44.
[43] Lee SK, Zhang W, Sanderson BJ. Selective growth inhibition of human leukemia
and human lymphoblastoid cells by resveratrol via cell cycle arrest and
apoptosis induction. J Agric Food Chem 2008;56:7572–7.
[44] Holcapek M, Kola´rova´ L, Nobilis M. High-performance liquid chromatography-
tandem mass spectrometry in the identification and determination of phase I
and phase II drug metabolites. Anal Bioanal Chem 2008;391:59–78.
[45] Yang J, Zhao XJ, Liu XL, Wang C, Gao P, Wang JS, et al. High performance liquid
chromatography-mass spectrometry for metabonomics: potential biomarkers
for acute deterioration of liver function in chronic hepatitis B. J Proteome Res
2006;5:554–61.
[17] Bishayee A. Cancer prevention and treatment with resveratrol: from rodent
studies to clinical trials. Cancer Prev Res 2009;2:409–18.
´
[18] Li Y, Ba¨ckesjo¨ CM, Haldosen LA, Lindgren U. Resveratrol inhibits proliferation
and promotes apoptosis of osteosarcoma cells. Eur J Pharmacol 2009;609:
13–8.
[19] Woo KJ, Lee TJ, Lee SH, Lee JM, Seo JH, Jeong YJ, et al. Elevated gadd153/chop
expression during resveratrol-induced apoptosis in human colon cancer cells.
Biochem Pharmacol 2007;73:68–76.
[20] Gescher AJ, Steward WP. Relationship between mechanisms, bioavailibility,
and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer
Epidemiol Biomarkers Prev 2003;12:953–7.
[46] Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB
2003;17:1975–85.
J
[47] Liska D, Lyon M, Jones DS. Detoxification and biotransformational imbalances.
Explore (NY) 2006;2:122–40.